|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped16 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped10 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped11 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped10 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped10 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped13 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped10 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped9 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped9 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped6 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped5 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped8 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped7 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped6 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped5 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped4 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Paclitaxel induced cystoid macular edema - reversed when chemo stopped9 views74 year old retired physician About 2-3 weeks ago there was gradual vision loss in the right eye. The patient was seen by an ophthalmologist who saw macular swelling and injected vabysmo. He has been on chemotherapy (Carbiplatin and Carboxytaxol for 2 cancers - advanced prostrate diagnosed 2019 - has had brain surgery AND squamous lung cancers treated with radiation)
Medical Hx: Prostate cancer (Onset: 2018). Pulmonary and bone cancer metastatic. Brain cancer metastasized from prostate cancer.
Surgical Hx: Right frontal & Frontoparietal Craniotomy (Onset: 2024). Appendectomy. Hemorrhoidectomy. Herniorrhaphy. Prostate. Systemic Meds: Chemotherapy. Radiation. Eligard Every 3 Months 22.5 MG per 0.375 ML Prefilled Syringe. MIRALAX prn. Tums Freshers 500 MG Chewable Tablet. Vitamin D. XGEVA.
VA OD: Dcc20/125+1
VA OS: Dcc20/125-2
TP: OD:12 OS:15Aug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome9 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome7 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome7 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome8 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome10 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome9 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome9 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome11 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome11 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome8 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome10 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome5 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome7 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome6 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome9 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome7 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome1 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome10 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome8 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome9 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcome14 views57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAug 17, 2025
|
|
Choroidal hemangioma 10 year old black male10 views10 year old black child The patient has been wearing glasses which for 3 years and the left eye has had a changing prescription.
3/13/23: OD: +1.00; OS: +5.50
7/18/24: OD: +1.00; OS: +8.00 -1.25 x 015
2/3/25: (Cycloplegic): OD: +2.00; OS: 11.50+1.50 x 120
She had an MRI scan was not diagnostic.
VA OD:20/16
OS: 20/30-2
B-scan 5.1 mm H x 12.3 mm A x 15.0 mm T highly reflective mass centered just temporal to the macula involving the entire macula).
Seen at Wills and observation was decided because of no macular fluidAug 13, 2025
|
|
Choroidal hemangioma 10 year old black male11 views10 year old black child The patient has been wearing glasses which for 3 years and the left eye has had a changing prescription.
3/13/23: OD: +1.00; OS: +5.50
7/18/24: OD: +1.00; OS: +8.00 -1.25 x 015
2/3/25: (Cycloplegic): OD: +2.00; OS: 11.50+1.50 x 120
She had an MRI scan was not diagnostic.
VA OD:20/16
OS: 20/30-2
B-scan 5.1 mm H x 12.3 mm A x 15.0 mm T highly reflective mass centered just temporal to the macula involving the entire macula).
Seen at Wills and observation was decided because of no macular fluidAug 13, 2025
|
|
Choroidal hemangioma 10 year old black male10 views10 year old black child The patient has been wearing glasses which for 3 years and the left eye has had a changing prescription.
3/13/23: OD: +1.00; OS: +5.50
7/18/24: OD: +1.00; OS: +8.00 -1.25 x 015
2/3/25: (Cycloplegic): OD: +2.00; OS: 11.50+1.50 x 120
She had an MRI scan was not diagnostic.
VA OD:20/16
OS: 20/30-2
B-scan 5.1 mm H x 12.3 mm A x 15.0 mm T highly reflective mass centered just temporal to the macula involving the entire macula).
Seen at Wills and observation was decided because of no macular fluidAug 13, 2025
|
|
Roth Spot and Endocarditis7 views70 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisAug 13, 2025
|
|
Roth Spot and Endocarditis5 views70 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisAug 13, 2025
|
|
Roth Spot and Endocarditis6 views70 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisAug 13, 2025
|
|
Roth Spot and Endocarditis8 views70 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisAug 13, 2025
|
|
Roth Spot and Endocarditis4 views70 year old female - flu like symptoms with roth spot who was diagnosed by echo with endocarditisAug 13, 2025
|
|
Choroidal Nevus with Halo12 viewsAug 13, 2025
|
|
Choroidal Nevus with Halo7 viewsAug 13, 2025
|
|
Choroidal Nevus with Halo12 viewsAug 13, 2025
|
|
Choroidal Nevus with Halo9 viewsAug 13, 2025
|
|
CRAO and NVI (rubeosis)4 viewsAug 13, 2025
|
|
CRAO and NVI (rubeosis)14 viewsAug 13, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)15 views23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Jul 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)13 views23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Jul 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)16 views23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Jul 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)13 views23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Jul 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)7 views23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Jul 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)16 views23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Jul 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)7 views23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Jul 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)8 views23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Jul 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)11 views23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Jul 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)10 views23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Jul 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)8 views23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Jul 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)9 views23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Jul 28, 2025
|
|
Optic Neuritis sentinel event for MS (23 year old female)14 views23-year-old female contact lens wearer reports recurrent blurry vision with a central "blob" in the right eye, first occurring in December 2024 for two weeks, then briefly affecting the left eye, and now recurring in the right eye. Symptoms have been painless, with no eye movement discomfort or neurological changes.
Medical/Surgical Hx: Noncontributory
Meds: Lo Loestrin
VA: OD 20/40 PH 20/30; OS 20/25
IOP: OD 17, OS 18Jul 28, 2025
|
|
Bear tracks (and diabetic retinopathy)15 views48 year old female with bear tracks in her retina and NPDR.Jul 28, 2025
|
|
Bear tracks (and diabetic retinopathy)15 views48 year old female with bear tracks in her retina and NPDR.Jul 28, 2025
|
|
Bear tracks (and diabetic retinopathy)11 views48 year old female with bear tracks in her retina and NPDR.Jul 28, 2025
|
|
Bear tracks (and diabetic retinopathy)10 views48 year old female with bear tracks in her retina and NPDR.Jul 28, 2025
|
|
Bear tracks (and diabetic retinopathy)14 views48 year old female with bear tracks in her retina and NPDR.Jul 28, 2025
|
|
Bear tracks (and diabetic retinopathy)12 views48 year old female with bear tracks in her retina and NPDR.Jul 28, 2025
|
|
Bear tracks (and diabetic retinopathy)15 views48 year old female with bear tracks in her retina and NPDR.Jul 28, 2025
|
|
Bear tracks (and diabetic retinopathy)14 views48 year old female with bear tracks in her retina and NPDR.Jul 28, 2025
|
|
Bear tracks (and diabetic retinopathy)12 views48 year old female with bear tracks in her retina and NPDR.Jul 28, 2025
|
|
Bear tracks (and diabetic retinopathy)9 views48 year old female with bear tracks in her retina and NPDR.Jul 28, 2025
|
|
Bear tracks (and diabetic retinopathy)13 views48 year old female with bear tracks in her retina and NPDR.Jul 28, 2025
|
|
Bear tracks (and diabetic retinopathy)16 views48 year old female with bear tracks in her retina and NPDR.Jul 28, 2025
|
|
Small choroidal melanoma11 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma12 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma12 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma14 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma12 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma12 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma12 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma13 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma10 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma11 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma18 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma12 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma9 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma8 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma11 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma13 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma13 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma8 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma13 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Small choroidal melanoma19 views28 year old man Serial images suggested that the lesion is growing
OD: sc20/16
OS: sc20/40+2
IOP: TP: OD:19 OS:16 Jul 28, 2025
|
|
Acute retinal necrosis12 views67 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODJul 28, 2025
|
|
Acute retinal necrosis11 views67 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODJul 28, 2025
|
|
Acute retinal necrosis12 views67 year old female Hazy vision in the right eye for 5 days.
Medical Hx: TYPE 2 DIAB.. Hypercholesterolemia.
Surgical Hx: COLECTOMY.
Systemic Meds: CRESTOR 10 MG QD. METFORMIN 500 MG QD. PROLIA Q 6 MOS. SULFA 800 MG/ TRIMETHOPRIM 160 MG TID. VALCYCLOVIR 1 GM TID. PROBIOTIC QD. CENTRUM 50+ QD. ALLERGY MED QD
VA 20/40, 20/20
IOP 19, 12
SLE: Trace AC cell OD and moderate vitreous cell ODJul 28, 2025
|
|
| 17549 files on 176 page(s) |
1 |
 |
|
|
|
|
|
|
|
|
|
